💊 Rahika (Capmatinib 150 mg) Tablets

Rahika (Capmatinib 150 mg) Tablets is a targeted anti-cancer medicine used primarily for the treatment of non-small cell lung cancer (NSCLC) with specific genetic mutations (MET exon 14 skipping mutation).

Capmatinib belongs to a class of drugs known as kinase inhibitors, which work by blocking abnormal proteins that signal cancer cells to grow, thereby slowing or stopping tumor progression.

💊 How to Use

• Take Rahika tablets exactly as prescribed by your oncologist

• Usually taken orally, with or without food

• Swallow whole with water (do not crush or chew)

• Take doses at the same time every day for best results

• If a dose is missed, follow your doctor’s advice (do not double dose)

🎯 Uses

Rahika (Capmatinib 150 mg) Tablets are used for:

• Treatment of Non-small cell lung cancer (NSCLC)

• Patients with MET exon 14 skipping mutation-positive cancer

• Advanced or metastatic lung cancer cases

💉 Dosage

• Standard dose: 400 mg twice daily (or as prescribed)

• Dose adjustments may be required based on:

  • Patient condition

  • Side effects

  • Liver/kidney function

⚠️ Always follow the doctor’s prescription strictly

✅ Advantages

• ✔️ Targeted therapy with precision action

• ✔️ Effective for mutation-specific lung cancer

• ✔️ Helps slow tumor growth and spread

• ✔️ Oral administration (more convenient than injections)

• ✔️ Improves survival outcomes in advanced NSCLC

📦 Storage Conditions

• Store at room temperature (20°C–25°C)

• Keep away from heat, moisture, and direct sunlight

• Store in original packaging

• Keep out of reach of children

🇮🇳 Alternative Indian Brands of Capmatinib Tablets

Some available alternatives to Rahika include:

• Tabrecta (Capmatinib Tablets) – by Novartis

• Capmatinib Tablets (generic versions) – by Natco Pharma

• Capmatinib formulations – by Dr. Reddy's Laboratories

(Availability depends on export approvals and country regulations.)

🌍 Why Choose GlobMedIndia Exporter?

GlobMedIndia is a trusted name in global pharmaceutical exports:

• ✔️ Certified and high-quality oncology medicines

• ✔️ Affordable pricing for global patients

• ✔️ Secure packaging & temperature-controlled shipping

• ✔️ Fast doorstep delivery worldwide

• ✔️ Complete export documentation support

🚚 Delivery Coverage in Africa

We provide safe and fast delivery to:

• South Africa

• Botswana

• Lesotho

• Mozambique

• Namibia

• Eswatini

• Zimbabwe

Buy Rahika (Capmatinib 150 mg) Tablets Online – GlobMedIndia Exporter

Order Rahika Capmatinib 150 mg Tablets online from GlobMedIndia. Trusted exporter of anti-cancer medicines with fast delivery to South Africa, Botswana, Namibia, Zimbabwe & more.

Looking to buy Rahika (Capmatinib 150 mg) Tablets online? GlobMedIndia is a leading exporter of high-quality oncology medicines from India. Capmatinib is a targeted therapy used in the treatment of non-small cell lung cancer (NSCLC) with MET mutations.

We ensure safe packaging, competitive pricing, and fast doorstep delivery across South Africa, Botswana, Lesotho, Mozambique, Namibia, Eswatini, and Zimbabwe.

Choose GlobMedIndia for genuine anti-cancer medicines and reliable global export services. Contact us today to place your order.

• Rahika Capmatinib 150 mg Tablets

• Capmatinib tablets India exporter

• Buy Capmatinib online

• NSCLC targeted therapy drugs

• MET exon 14 skipping mutation treatment

• Lung cancer medicine Capmatinib

• Oncology medicines exporter India

• Capmatinib South Africa supplier

• Anti cancer tablets Africa delivery

• GlobMedIndia cancer medicines

• Capmatinib Botswana Namibia Zimbabwe

• Affordable lung cancer treatment India

📌 Conclusion

Rahika (Capmatinib 150 mg) Tablets is a breakthrough targeted therapy for patients with advanced Non-small cell lung cancer, offering improved outcomes and precision treatment.

With GlobMedIndia Exporter, patients across Africa can access genuine medicines with fast, safe, and reliable delivery—making life-saving cancer treatments more accessible globally.

https://globmedindia.com